The Scientific & Medical Team at Nanostics is responsible for leading research and development initiatives to create innovative diagnostic tests for aggressive prostate cancer. This team works closely with clinical and regulatory bodies to ensure the accuracy and reliability of diagnostic methodologies, while also collaborating with external partners to advance scientific knowledge and improve patient outcomes. Their expertise drives the translation of scientific research into actionable medical solutions.
View all